Skip to main content
Top
Published in: BMC Urology 1/2020

01-12-2020 | Dyslipidemia | Research article

Elevated non-high-density lipoprotein cholesterol corresponds to a high risk of nephrolithiasis in children

Authors: Meiyuan Chen, Jing Xiao, Yuan Du, Miaomiao Wang, Jimeng Ruan, Ye Tian

Published in: BMC Urology | Issue 1/2020

Login to get access

Abstract

Background

Dyslipidemia contributes to the development of nephrolithiasis in adults; however its relationship to urolithiasis in children remains debatable, and will be clarified in the present work.

Methods

A case–control study was performed involving 58 pediatric patients diagnosed with upper urinary tract stones as well as 351 controls. Age, gender, body mass index (BMI), serum calcium, serum uric acid, blood glucose, blood lipids, and compositions of stones were compared.

Results

According to the univariate analysis, uric acid was higher (P < 0.01) but serum calcium lower in the stone group than the control (P < 0.05). As for the blood lipids, non-high-density lipoprotein cholesterol (non-HDL-c) was significantly higher in the stone group as compared to the control (P < 0.01), while total cholesterol, triglycerides, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol did not show statistical difference between the two groups. In the multivariate analysis, only non-HDL-c and serum uric acid were increased in the stone group (P = 0.003 and P = 0.008). In the stone compositions’ analysis, serum uric acid and non-HDL-c were associated with percentage of uric acid and pure calcium oxalate stones, respectively.

Conclusion

Non-high-density lipoprotein cholesterol may act as a lipid risk factor for urolithiasis in children.
Literature
1.
go back to reference Tasian GE, Copelovitch L. Evaluation and medical management of kidney stones in children. J Urol. 2014;192:1329–36.CrossRef Tasian GE, Copelovitch L. Evaluation and medical management of kidney stones in children. J Urol. 2014;192:1329–36.CrossRef
2.
go back to reference Hernandez JD, Ellison JS, Lendvay TS. Current trends, evaluation, and Management of Pediatric Nephrolithiasis. JAMA Pediatr. 2015;169:964–70.CrossRef Hernandez JD, Ellison JS, Lendvay TS. Current trends, evaluation, and Management of Pediatric Nephrolithiasis. JAMA Pediatr. 2015;169:964–70.CrossRef
3.
go back to reference Routh JC, Graham DA, Nelson CP. Epidemiological trends in pediatric urolithiasis at United States freestanding pediatric hospitals. J Urol. 2010;184:1100–4.CrossRef Routh JC, Graham DA, Nelson CP. Epidemiological trends in pediatric urolithiasis at United States freestanding pediatric hospitals. J Urol. 2010;184:1100–4.CrossRef
4.
go back to reference Dwyer ME, Krambeck AE, Bergstralh EJ, Milliner DS, Lieske JC, Rule AD. Temporal trends in incidence of kidney stones among children: a 25-year population based study. J Urol. 2012;188:247–52.CrossRef Dwyer ME, Krambeck AE, Bergstralh EJ, Milliner DS, Lieske JC, Rule AD. Temporal trends in incidence of kidney stones among children: a 25-year population based study. J Urol. 2012;188:247–52.CrossRef
5.
go back to reference Cameron MA, Sakhaee K, Moe OW. Nephrolithiasis in children. Pediatr Nephrol. 2005;20:1587–92.CrossRef Cameron MA, Sakhaee K, Moe OW. Nephrolithiasis in children. Pediatr Nephrol. 2005;20:1587–92.CrossRef
6.
go back to reference Kang HW, Lee SK, Kim WT, Kim YJ, Yun SJ, Lee SC, et al. Hypertriglyceridemia and low high-density lipoprotein cholesterolemia are associated with increased hazard for urolithiasis. J Endourol. 2014;28:1001–5.CrossRef Kang HW, Lee SK, Kim WT, Kim YJ, Yun SJ, Lee SC, et al. Hypertriglyceridemia and low high-density lipoprotein cholesterolemia are associated with increased hazard for urolithiasis. J Endourol. 2014;28:1001–5.CrossRef
7.
go back to reference Kang HW, Seo SP, Kim WT, Kim YJ, Yun SJ, Lee SC, et al. Hypertriglyceridemia is associated with increased risk for stone recurrence in patients with urolithiasis. Urology. 2014;84:766–71.CrossRef Kang HW, Seo SP, Kim WT, Kim YJ, Yun SJ, Lee SC, et al. Hypertriglyceridemia is associated with increased risk for stone recurrence in patients with urolithiasis. Urology. 2014;84:766–71.CrossRef
8.
go back to reference Torricelli FC, De SK, Gebreselassie S, Li I, Sarkissian C, Monga M. Dyslipidemia and kidney stone risk. J Urol. 2014;191:667–72.CrossRef Torricelli FC, De SK, Gebreselassie S, Li I, Sarkissian C, Monga M. Dyslipidemia and kidney stone risk. J Urol. 2014;191:667–72.CrossRef
9.
go back to reference Masterson JH, Woo JR, Chang DC, Chi T, L'Esperance JO, Stoller ML, et al. Dyslipidemia is associated with an increased risk of nephrolithiasis. Urolithiasis. 2015;43:49–53.CrossRef Masterson JH, Woo JR, Chang DC, Chi T, L'Esperance JO, Stoller ML, et al. Dyslipidemia is associated with an increased risk of nephrolithiasis. Urolithiasis. 2015;43:49–53.CrossRef
10.
go back to reference Kirejczyk JK, Korzeniecka-Kozerska A, Baran M, Porowska H, Porowski T, Wasilewska A. Dyslipidaemia in overweight children and adolescents is associated with an increased risk of kidney stones. Acta Paediatr. 2015;104:e407–13.CrossRef Kirejczyk JK, Korzeniecka-Kozerska A, Baran M, Porowska H, Porowski T, Wasilewska A. Dyslipidaemia in overweight children and adolescents is associated with an increased risk of kidney stones. Acta Paediatr. 2015;104:e407–13.CrossRef
11.
go back to reference Jellinger PS, Handelsman Y, Rosenblit PD, Bloomgarden ZT, Fonseca VA, Garber AJ, et al. American association of clinical endocrinologists and american college of endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease. Endocr Pract. 2017;23:1–87.CrossRef Jellinger PS, Handelsman Y, Rosenblit PD, Bloomgarden ZT, Fonseca VA, Garber AJ, et al. American association of clinical endocrinologists and american college of endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease. Endocr Pract. 2017;23:1–87.CrossRef
12.
go back to reference Li H, Zong XN, Ji CY, Mi J. Body mass index cut-offs for overweight and obesity in Chinese children and adolescents aged 2–18 years. Zhonghua Liu Xing Bing Xue Za Zhi. 2010;31:616–20.PubMed Li H, Zong XN, Ji CY, Mi J. Body mass index cut-offs for overweight and obesity in Chinese children and adolescents aged 2–18 years. Zhonghua Liu Xing Bing Xue Za Zhi. 2010;31:616–20.PubMed
13.
go back to reference Li H, Ji CY, Zong XN, Zhang YQ. Body mass index growth curves for Chinese children and adolescents aged 0 to 18 years. Zhonghua Er Ke Za Zhi. 2009;47:493–8.PubMed Li H, Ji CY, Zong XN, Zhang YQ. Body mass index growth curves for Chinese children and adolescents aged 0 to 18 years. Zhonghua Er Ke Za Zhi. 2009;47:493–8.PubMed
14.
go back to reference Xiang W. Experts consensus for prevention and treatment of dyslipidemia in children and adolescents. Zhonghua Er Ke Za Zhi. 2009;47:426–8. Xiang W. Experts consensus for prevention and treatment of dyslipidemia in children and adolescents. Zhonghua Er Ke Za Zhi. 2009;47:426–8.
15.
go back to reference Hirsch G, Vaid N, Blumenthal RS. Perspectives: the significance of measuring non-HDL-cholesterol. Prev Cardiol. 2002;5:156–9.CrossRef Hirsch G, Vaid N, Blumenthal RS. Perspectives: the significance of measuring non-HDL-cholesterol. Prev Cardiol. 2002;5:156–9.CrossRef
16.
go back to reference Stoller ML, Meng MV, Abrahams HM, Kane JP. The primary stone event: a new hypothesis involving a vascular etiology. J Urol. 2004;171:1920–4.CrossRef Stoller ML, Meng MV, Abrahams HM, Kane JP. The primary stone event: a new hypothesis involving a vascular etiology. J Urol. 2004;171:1920–4.CrossRef
17.
go back to reference Yencilek E, Sari H, Yencilek F, Yesil E, Aydin H. Systemic endothelial function measured by flow-mediated dilation is impaired in patients with urolithiasis. Urolithiasis. 2017;45:545–52.CrossRef Yencilek E, Sari H, Yencilek F, Yesil E, Aydin H. Systemic endothelial function measured by flow-mediated dilation is impaired in patients with urolithiasis. Urolithiasis. 2017;45:545–52.CrossRef
18.
go back to reference Taylor ER, Stoller ML. Vascular theory of the formation of Randall plaques. Urolithiasis. 2015;43(Suppl 1):41–5.CrossRef Taylor ER, Stoller ML. Vascular theory of the formation of Randall plaques. Urolithiasis. 2015;43(Suppl 1):41–5.CrossRef
19.
go back to reference Khan SR, Rodriguez DE, Gower LB, Monga M. Association of Randall plaque with collagen fibers and membrane vesicles. J Urol. 2012;187:1094–100.CrossRef Khan SR, Rodriguez DE, Gower LB, Monga M. Association of Randall plaque with collagen fibers and membrane vesicles. J Urol. 2012;187:1094–100.CrossRef
20.
go back to reference Verrier C, Bazin D, Huguet L, Stephan O, Gloter A, Verpont MC, et al. Topography, composition and structure of incipient Randall plaque at the Nanoscale level. J Urol. 2016;196:1566–74.CrossRef Verrier C, Bazin D, Huguet L, Stephan O, Gloter A, Verpont MC, et al. Topography, composition and structure of incipient Randall plaque at the Nanoscale level. J Urol. 2016;196:1566–74.CrossRef
21.
go back to reference Sur RL, Masterson JH, Palazzi KL, L'Esperance JO, Auge BK, Chang DC, et al. Impact of statins on nephrolithiasis in hyperlipidemic patients: a 10-year review of an equal access health care system. Clin Nephrol. 2013;79:351–5.CrossRef Sur RL, Masterson JH, Palazzi KL, L'Esperance JO, Auge BK, Chang DC, et al. Impact of statins on nephrolithiasis in hyperlipidemic patients: a 10-year review of an equal access health care system. Clin Nephrol. 2013;79:351–5.CrossRef
22.
go back to reference Cohen AJ, Adamsky MA, Nottingham CU, Pruitt J, Lapin B, Wang CH, et al. Impact of statin intake on kidney stone formation. Urology. 2019;124:57–61.CrossRef Cohen AJ, Adamsky MA, Nottingham CU, Pruitt J, Lapin B, Wang CH, et al. Impact of statin intake on kidney stone formation. Urology. 2019;124:57–61.CrossRef
23.
go back to reference Ren J, Grundy SM, Liu J, Wang W, Wang M, Sun J, et al. Long-term coronary heart disease risk associated with very-low-density lipoprotein cholesterol in Chinese: the results of a 15-year Chinese multi-provincial cohort study (CMCS). Atherosclerosis. 2010;211:327–32.CrossRef Ren J, Grundy SM, Liu J, Wang W, Wang M, Sun J, et al. Long-term coronary heart disease risk associated with very-low-density lipoprotein cholesterol in Chinese: the results of a 15-year Chinese multi-provincial cohort study (CMCS). Atherosclerosis. 2010;211:327–32.CrossRef
24.
go back to reference Sun X, Shen L, Cong X, Zhu H, He L, Lu J. Infrared spectroscopic analysis of 5,248 urinary stones from Chinese patients presenting with the first stone episode. Urol Res. 2011;39:339–43.CrossRef Sun X, Shen L, Cong X, Zhu H, He L, Lu J. Infrared spectroscopic analysis of 5,248 urinary stones from Chinese patients presenting with the first stone episode. Urol Res. 2011;39:339–43.CrossRef
25.
go back to reference Lopez M, Hoppe B. History, epidemiology and regional diversities of urolithiasis. Pediatr Nephrol. 2010;25:49–59.CrossRef Lopez M, Hoppe B. History, epidemiology and regional diversities of urolithiasis. Pediatr Nephrol. 2010;25:49–59.CrossRef
26.
go back to reference Cloutier J, Villa L, Traxer O, Daudon M. Kidney stone analysis: "give me your stone, I will tell you who you are!". World J Urol. 2015;33:157–69.CrossRef Cloutier J, Villa L, Traxer O, Daudon M. Kidney stone analysis: "give me your stone, I will tell you who you are!". World J Urol. 2015;33:157–69.CrossRef
27.
go back to reference Bevill M, Kattula A, Cooper CS, Storm DW. The modern metabolic stone evaluation in children. Urology. 2017;101:15–20.CrossRef Bevill M, Kattula A, Cooper CS, Storm DW. The modern metabolic stone evaluation in children. Urology. 2017;101:15–20.CrossRef
28.
go back to reference Tekin A, Tekgul S, Atsu N, Sahin A, Ozen H, Bakkaloglu M. A study of the etiology of idiopathic calcium urolithiasis in children: hypocitruria is the most important risk factor. J Urol. 2000;164:162–5.CrossRef Tekin A, Tekgul S, Atsu N, Sahin A, Ozen H, Bakkaloglu M. A study of the etiology of idiopathic calcium urolithiasis in children: hypocitruria is the most important risk factor. J Urol. 2000;164:162–5.CrossRef
29.
go back to reference Lim DH, Kim MH, Hong S, Kim YG, Ji SO. Is the serum uric acid level independently associated with incidental Urolithiasis? J Rheum Dis. 2018;25:116–21.CrossRef Lim DH, Kim MH, Hong S, Kim YG, Ji SO. Is the serum uric acid level independently associated with incidental Urolithiasis? J Rheum Dis. 2018;25:116–21.CrossRef
Metadata
Title
Elevated non-high-density lipoprotein cholesterol corresponds to a high risk of nephrolithiasis in children
Authors
Meiyuan Chen
Jing Xiao
Yuan Du
Miaomiao Wang
Jimeng Ruan
Ye Tian
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Urology / Issue 1/2020
Electronic ISSN: 1471-2490
DOI
https://doi.org/10.1186/s12894-020-00691-6

Other articles of this Issue 1/2020

BMC Urology 1/2020 Go to the issue